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Transcriptome-based network 
analysis reveals renal cell type-
specific dysregulation of hypoxia-
associated transcripts
Natallia Shved1, Gregor Warsow2, Felix Eichinger3, David Hoogewijs4, Simone Brandt5,  
Peter Wild5, Matthias Kretzler3, Clemens D. Cohen1,6 & Maja T. Lindenmeyer1,6
Accumulating evidence suggests that dysregulation of hypoxia-regulated transcriptional mechanisms 
is involved in development of chronic kidney diseases (CKD). However, it remains unclear how 
hypoxia-induced transcription factors (HIFs) and subsequent biological processes contribute to CKD 
development and progression. In our study, genome-wide expression profiles of more than 200 renal 
biopsies from patients with different CKD stages revealed significant correlation of HIF-target genes 
with eGFR in glomeruli and tubulointerstitium. These correlations were positive and negative and in 
part compartment-specific. Microarrays of proximal tubular cells and podocytes with stable HIF1α  
and/or HIF2α suppression displayed cell type-specific HIF1/HIF2-dependencies as well as dysregulation 
of several pathways. WGCNA analysis identified gene sets that were highly coregulated within 
modules. Characterization of the modules revealed common as well as cell group- and condition-specific 
pathways, GO-Terms and transcription factors. Gene expression analysis of the hypoxia-interconnected 
pathways in patients with different CKD stages revealed an increased dysregulation with loss of renal 
function. In conclusion, our data clearly point to a compartment- and cell type-specific dysregulation 
of hypoxia-associated gene transcripts and might help to improve the understanding of hypoxia, HIF 
dysregulation, and transcriptional program response in CKD.
Chronic kidney disease (CKD) is a major and rapidly increasing worldwide public health problem that is associ-
ated with an excessively increased cardiovascular risk profile, significant mortality and socioeconomic burden1, 2. 
Most CKDs are initiated by glomerular alterations. The pathogenesis of the glomerular insult can be variable, 
including diabetes, hypertension and glomerulonephritis2–4. With ongoing progression irreversible pathological 
processes occur in the tubulointerstitium resulting in the development of end-stage renal disease (ESRD). The 
best morphologic indicator of disease progression and development of ESRD is currently the degree of interstitial 
fibrosis5.
One of the mechanisms which has been implicated in the development of tissue fibrosis is hypoxia caused by 
an imbalance of blood perfusion and oxygen demand6. The cellular response to hypoxia is largely mediated by 
the hypoxia-inducible factors (HIF), heterodimeric transcription factors consisting of a labile oxygen-regulated 
α-subunit, including HIF1α, HIF2α and HIF3α and a constitutively expressed β-subunit (HIFβ)7. The HIF iso-
forms and regulators of HIF (prolyl hydroxylases) show partly cell type-specific distributions in the kidney. While 
HIF1α is mainly found in tubular cells, HIF2α is expressed essentially in endothelial and interstitial cells, as well 
as in some glomerular cells8, 9. HIF expression is not apparent in the normal renal medulla despite physiologically 
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low oxygen tension. Upregulation of HIF occurs in response to reduced oxygen content of the blood and, more-
over, tubular cells differ in their hypoxia HIF response capacity. This capacity is most pronounced in collecting 
duct, less in proximal tubules and limited in thick limb8.
For more than a decade the “chronic hypoxia hypothesis” links hypoxia to tubular damage in CKD, with 
hypoxia acting as the transmitter of glomerular injury to the tubulointerstitium10. According to this idea, the 
glomerular damage leads to reduced postglomerular flow and tubulointerstitial hypoxia with subsequent tubu-
lar injury, inflammation, fibrosis and capillary rarefaction. Accumulating data from in vitro and animal studies 
support the presence of hypoxia and its potential pathogenic role in the chronic deterioration of renal function. 
The group of Nangaku could demonstrate that hypoxia induces a myofibroblastic phenotype in tubular epithelial 
cells and that prolonged exposure to hypoxia leads to mitochondrial dysfunction and subsequent apoptosis11, 12. 
Higgins and colleagues found that activation of epithelial HIF1α signaling is associated with the development of 
CKD and might contribute to the development of interstitial fibrosis via the induction of ECM-modifying and 
lysyl oxidase genes13.
In humans, evidence remains unclear as studies show divergent results. Immunohistochemistry data from 
kidney biopsies of patients with diabetic nephropathy, IgA-nephropathy or polycystic kidney disease display an 
increased expression of HIF1α, used as an indirect marker for hypoxia13–15, suggesting thereby the presence of 
hypoxia in these diseases. Additionally, data from patients with nephrosclerosis indicate that hypoxia-associated 
processes seem not only to be involved in tubulointerstitial fibrosis, but might also contribute to glomerular dam-
age via upregulation of CXCR416. On the other hand patients with advanced stages of CKD show despite anemia 
an impaired expression of erythropoetin as well as reduced expression of vascular endothelial growth factor A 
(VEGFA), both genes known to be induced by hypoxia15, 17. Furthermore, recent BOLD-MRI studies measuring 
renal oxygenation in CKD patients gave discrepant findings on whether renal oxygenation is reduced in CKD 
patients or not18, 19.
Since hypoxia has been associated with fibrosis, renal cells indeed might face hypoxia in CKD and respond 
with a transcriptional program which could lead to progression of renal disease. So, the aim of the study was 
to analyze 1) whether an eGFR-dependent induction of HIF-target genes can be detected in kidney biopsies of 
patients with CKD as support for the chronic hypoxia hypothesis, 2) which relevance HIFs have in the dysregula-
tion of hypoxia-associated gene products in different renal cells and 3) which additional regulatory mechanisms 
might be involved and might contribute to disease progression.
Results
eGFR Correlation of HIF-target genes. To investigate whether an eGFR-dependent induction of HIF-
target genes can be detected in patients with CKD, glomerular and tubulointerstitial expression of 83 litera-
ture-derived HIF-target genes20, 21 in patients with different glomerulopathies were correlated to eGFR using 
Spearman correlation. From a total of 83 HIF-target genes, 24 correlated with eGFR in the tubulointerstitium 
and 18 correlated with eGFR in glomerular samples (correlation criteria: ISpearman’s rhoI >0.3; FDR-corrected 
p-value < 0.05; Table 1). In order to estimate the significance of this finding, bootstrap correlation analyses were 
performed on glomerular and tubulointerstitial gene expression data by selection of 10,000 sets of 83 randomly 
chosen genes and subsequent determination of the number of genes that correlated significantly with eGFR (same 
correlation criteria as above). As a result, the observed enrichment for hypoxia-associated genes being correlated 
with eGFR is very unlikely to have occurred just by chance for glomerular samples, which does not hold for the 
tubulointerstitium (Supplementary Figure 1A and B). The findings were robust with respect to gene selection 
when we used bootstrap sample analyses for randomly chosen subsets of 60%, 70%, 80%, and 90% of the 83 HIF-
target genes (Supplementary Figure 1C and D). While age did not correlate with gene expression indicating no 
influence of age on eGFR-dependent induction of HIF-target genes (data not shown), stratification by gender 
revealed sex-specific differences in correlation of eGFR and HIF target gene expression (Supplementary Table 1, 
Supplementary Figure 1E–H).
Interestingly, we did not see a continuous induction of the HIF-target genes which would result in a nega-
tive correlation with eGFR, but rather observed correlations that were both positive and negative and in part 
compartment-specific.
Evaluation of selected HIF-targets by immunohistochemistry. For evaluation of protein expression 
in human biopsies, immunohistochemistry of HIF1α, which showed a negative correlation with eGFR on tran-
scriptomic level, and ATP binding cassette subfamily G member 2 (ABCG2) as well as VEGFA, both positively 
correlating with eGFR, was performed on a set of kidney biopsies of patients with CKD with normal and reduced 
eGFR (Fig. 1, Supplementary Figure 2). In patients with normal eGFR, no nuclear or cytoplasmic staining of 
HIF1α was detected in the glomerular or tubular compartment (score 0), only erythrocytes showed unspecific 
staining. In diseased kidneys with reduced renal function an increased nuclear and cytoplasmic expression (score 
1) of HIF1α was found in tubular (p = 0.036) and to a lesser extent in glomerular cells (p = 0.007) which is in 
accordance with the transcriptomic correlation analysis and data from Higgins et al.13 (Fig. 1A, Supplementary 
Figure 2C and D). For ABCG2, a xenobiotic transporter, strong protein expression (score 2) could be detected 
in tubular epithelial cells in kidneys with normal eGFR, while the staining was clearly less intensive (weak, score 
1) in some diseased kidneys with reduced eGFR (p < 0.001) (Fig. 1B, Supplementary Figure 2E). The angiogenic 
factor VEGFA showed strong tubular (score 2) and only very weak staining in the glomerulus of the kidney with 
normal eGFR, and was less intensive (weak, score 1) in the tubulointerstitium in a subset of diseased kidneys 
with reduced eGFR (p = 0.001) (Fig. 1C, Supplementary Figure 2F). Overall, immunoreactivity levels of selected 
HIF-target genes in diseased kidney tissue with normal and reduced eGFR showed patterns comparable to the 
transcriptomic correlation analysis.
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Generation of stable HIF knockdown cells and microarray analysis. As the Spearman correlation 
analysis displayed a partial compartment-specific correlation pattern and no congruent correlation over all ana-
lyzed HIF-targets, we wanted to understand the cell type-specific response to hypoxia and the relevance of given 
HIFs of selected renal cells. As previous studies could show that podocytes in the glomerulus and proximal tubu-
lar cells in the tubulointerstitium are the most effected cell types in the kidney6, 16 and to our knowledge till now 
no hypoxia and HIF-dependent gene expression profiles exist for either cell type, we generated proximal tubular 
cells (HK-2) and podocytes (AB81) with stable HIF1α and/or HIF2α suppression.
To confirm the successful suppression of both transcription factors, the cells were subjected to normoxia (N, 
20% O2) or hypoxia (H, 1% O2) for 4 h or 24 h and whole cell protein extracts were immunoblotted for HIF1α and 
HIF2α. Immunoblot analysis revealed efficient stable HIF1α and/or HIF2α knockdown in both HK-2 cells and 
podocytes (Supplementary Figure 3).
To obtain a general overview of the hypoxia-response (24 h) gene expression profiles were generated. HK-2 
microarrays displayed significant upregulation of 569 genes (Fold Change (FC) >1.5, q < 5%) and downregula-
tion of 117 genes (FC < 0.667, q < 5%) under hypoxia, while in podocytes (AB81), 780 genes (FC >1.5, q < 5%) 
were significantly up- and 865 genes (FC < 0.667, q < 5%) significantly downregulated (Supplementary Table 2).
Microarray data analysis of these cells revealed partial cell type-specific HIF1α/HIF2α-dependencies of dif-
ferentially regulated genes (Supplementary Table 2).
Quantitative RT-PCR of selected HIF-target genes was used to validate the microarray results of renal HIF 
knockdown cells. E.g. the well-characterized HIF-target genes carboanhydrase 9 (CA9) and VEGFA showed sim-
ilar expression patterns in both cell lines. CA9 was strongly induced by hypoxia in both cells, which was abol-
ished specifically in the absence of HIF1α. The classical HIF-target gene VEGFA displayed a moderate hypoxic 
induction in AB81 and HK-2 which was only lost when both HIFα isoforms were ablated. The BCL2/Adenovirus 
E1B 19 kDa Interacting Protein 3 (BNIP3), a well-established HIF-target gene, displayed a cell type-specific 
HIF1α/HIF2α dependency. While in HK-2 cells BNIP3 was HIF1α-dependently induced by hypoxia, in AB81 
Entrez Gene 
ID Gene Symbol
eGFR (Glom) eGFR (Tub)
ρ ρ
9429 ABCG2 0.579
226 ALDOA −0.366
79365 BHLHE41 −0.335 −0.424
664 BNIP3 0.489
10370 CITED2 0.325
1356 CP −0.317
7852 CXCR4 −0.334 −0.504
54541 DDIT4 −0.356
1906 EDN1 −0.485
2023 ENO1 −0.356 −0.372
26355 FAM162A 0.304
2235 FECH 0.376
2597 GAPDH −0.321
3091 HIF1A −0.402 −0.484
7184 HSP90B1 −0.378
3484 IGFBP1 −0.383
3486 IGFBP3 −0.383
3689 ITGB2 −0.346 −0.511
4015 LOX 0.339
4017 LOXL2 −0.390 −0.323
4170 MCL1 −0.314 −0.471
4233 MET −0.445
4601 MXI1 0.508
10397 NDRG1 0.341 0.449
4878 NPPA 0.338
5209 PFKFB3 −0.441 −0.438
5366 PMAIP1 −0.316 −0.310
6095 RORA 0.418
5054 SERPINE1 −0.380
7037 TFRC −0.368
7422 VEGFA 0.579
7490 WT1 0.338
Table 1. Spearman Correlation Analysis for selected HIF-target genes with eGFR. Bold: ρ > І0.4І, adjusted 
p < 0.05; Italic: І0.4І > ρ > І0.3І, adjusted p < 0.05.
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no hypoxic induction was observed in wildtype cells. However, in HIF2α-knockdown cells a two-fold hypoxic 
induction of BNIP3 could be seen. While classical HIF-target genes such as VEGFA or CA9 behaved as expected 
under hypoxia in podocytes, there were genes such as epidermal growth factor (EGF) and C-C motif chemokine 
Figure 1. Immunohistochemistry of HIF1α, VEGFA and ABCG2. Sections from paraffin embedded kidney 
biopsies with chronic kidney disease (normal (left) and reduced eGFR (right)) were stained with antibodies 
against HIF1α (A), ATP binding cassette subfamily G member 2 (ABCG2) (B), and vascular endothelial growth 
factor A (VEGFA) (C). (A) No specific HIF1α staining could be detected in kidney sections with normal eGFR, 
score negative (0). Only some unspecific intravascular background staining is seen (left). In kidneys from 
patients with severely reduced eGFR, some nuclear (→) and cytoplasmic (►) tubular staining is detected, score 
weak (1) (right). (B) ABCG2 showing strong (score 2) expression in the tubulointerstitial compartment of 
kidneys with normal eGFR (left) in contrast to weak (score 1) staining in samples with reduced eGFR (right). 
(C) Similar stainig pattern for VEGFA, strong (score 2) expression in the tubulointerstitial compartment of 
kidneys with normal eGFR (left) in contrast to weak (score 1) staining in samples with reduced eGFR (right).
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ligand 5 (CCL5) that displayed unusual expression patterns. Expression of both genes was reduced under hypoxia 
compared to normoxic control. While hypoxic expression of EGF was further downregulated by ablation of 
HIF1α or HIF2α, CCL5 expression was decreased by HIF2α ablation, but showed a pronounced induction 
in HIF1α-knockdown cells. For most of the selected genes the microarray data could be confirmed by qPCR 
(Supplementary Table 3), excluding few genes, whose expression was either not detected with the method or 
showed a discrepant response to HIF-knockdown. Overall both methods were in broad agreement and consist-
ently revealed a partial HIF1α and/or HIF2α dependency for genes in renal cell lines.
Weighted Gene Co-expression Network Analysis. To investigate hypoxia-specific gene sets associated 
with the respective treatment, we performed a Weighted Gene Co-expression Network Analysis (WGCNA), TF 
enrichment and GlobalNet analysis (Workflow, Fig. 2).
We applied the WGCNA in order to identify groups (modules) of genes that showed highly co-expressed gene 
expression across the four cell groups (wt, HIF1kd, HIF2kd, HIF1 + 2kd) under a specific condition (hypoxia, 
normoxia). As a result, for both hypoxic and normoxic conditions, we got sets of genes (modules) that were 
highly co-expressed within the modules, but not necessarily between the modules. We identified 34 distinct 
co-expression modules for AB81 [13 modules (hypoxia), 21 modules (normoxia)] and 19 modules for HK-2 [7 
modules (hypoxia), 12 modules (normoxia)], respectively.
To identify gene sets correlating with HIF1α and/or HIF2α knockdown within one condition, the mod-
ule eigengene (ME) corresponding to the first principal component was calculated for each module and the 
ME-to-condition correlations were visualized as heatmaps (Supplementary Figure 4). In podocytes all cell 
groups significantly correlated with at least one module under hypoxic and normoxic conditions (Supplementary 
Figure 4A). While under hypoxic conditions in HK-2 cells no HIF2α correlation was observed, under normoxic 
condition one module (red) significantly correlated with HIF2α knockdown cell group. In contrast to HIF2α, 
a significant correlation of modules with the HIF1α knockdown under hypoxic conditions, but no significant 
HIF1α correlation under normoxia was observed (Supplementary Figure 4B).
Modules are enriched for genes with similar function. In a next step, we tried to link the module 
genes to biological information using a Gene Ontology (GO) analysis. Enriched GO Terms were collected across 
all modules for hypoxic and normoxic conditions Comparison between the different cell lines was performed 
resulting in six sets of GO Terms: common in hypoxia or normoxia, unique in podocytes or HK-2 cells under 
normoxic or hypoxic conditions (Supplementary Table 4). The GO Enrichment Analysis was combined with a 
network visualization of enriched GO Terms using the EnrichmentMap plugin for Cytoscape (see Materials and 
Methods).
GO Term analysis revealed major differences between hypoxic treated podocytes and HK-2 cells (Fig. 3). 
While podocytes were mainly associated with cell cycle processes, cell differentiation, steroid/cholesterol metab-
olism and inflammatory responses (Fig. 3A), hypoxia induced a gene expression pattern in HK-2 cells which 
was associated with morphogenesis and tube formation processes (Fig. 3B), regulation of transcriptional and 
biosynthetic processes as well as processes involved in angiogenesis and vitamin D receptor signaling. Common 
processes found in both cell lines included regulation of kidney development as well as uretic bud morphogenesis 
(Fig. 3C). Under normoxic conditions, no common GO processes were identified between the cell lines. In podo-
cytes, the GO network subdivided mainly into six major clusters including kidney morphogenesis, cell cycle pro-
cesses, cell differentiation, steroid/cholesterol metabolism, immune responses as well as angiogenesis (Fig. 3D). 
HK-2 cells however were among others associated with regulation of locomotion and cell migration (Fig. 3E).
Transcription factor (TF)-gene network. In a next step, we used the gene modules with a heatmap corre-
lation coefficient ≥0.8 and p ≤ 0.01 for the analysis of overrepresented TF-binding sites and generation of TF-gene 
networks. TFs which were found to be enriched and were common among podocyte and HK-2 cell groups 
under hypoxic conditions are involved in cell proliferation and cell differentiation processes and belong, among 
others, to the “Activator protein 2” (V$AP2F), “E2F-myc activator/cell cycle regulator” (V$E2FF), “Vertebrate 
homologues of enhancer of split complex” (V$HESF), “Pleomorphic adenoma gene” (V$PLAG), “GC-Box 
factors SP1/GC” (V$SP1F) and “Krueppel like transcription factors” (V$KLFS) TF-families (Supplementary 
Table 5). TF-families that were found only in hypoxic podocytes and not in HK-2 cells involved families such 
as “Myc-interacting Zn finger protein 1” (V$MIZ1) and “CP2-erythrocyte Factor related to drosophila Elf1” 
(V$CP2F), which are involved in cell cycle processes or regulate steroid metabolic processes. Under normoxic 
conditions, no common TF-families were found in all podocyte and HK-2 cell types. However, TF-families 
which were enriched in most cell types included again the “E2F-myc activator/cell cycle regulator” (V$E2FF), 
“Pleomorphic adenoma gene” (V$PLAG), “GC-Box factors SP1/GC” (V$SP1F) and “Krueppel like transcription 
factors” (V$KLFS) TF-families. TF- families that were unique to normoxic podocytes involved families such as 
“Sterol regulatory element binding proteins” (V$SREB), V$CP2F, “Twist subfamily of class B bHLH transcription 
factors” (V$HAND) or “RXR heterodimer binding sites” (V$RXRF) that regulate lipid and steroid metabolic 
processes, angiogenesis and immune responses. TFs of the “Nuclear factor of activated T-cells” (V$NFAT) family, 
known to be involved in cell migration and NFAT-signaling, as well as TFs of the “Ubiquitous GLI - Krueppel 
like zinc finger involved in cell cycle regulation” (V$E4FF) family, known regulators of cell proliferation, were 
exclusively enriched in normoxic HK-2 cells (Supplementary Table 5).
In a next step, those single TFs were identified, which made a TF-family (identified with the Genomatix 
TF-enrichment analysis) being called enriched. These selected TFs were then combined with their target genes 
resulting in a regulatory network of enriched TFs and their regulated genes. The resulting TF-gene regulatory net-
works were visualized with Cytoscape (Figs 4 and 5). The hypoxia podocyte TF-gene network (Fig. 4A) consisted 
of 1837 nodes, 53175 edges and was denser and larger than the tubular network (Fig. 4B), which was compiled 
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of 775 nodes and 24799 edges. Comparison of both hypoxic TF-gene networks showed a very marginal overlap 
between the cell types (Fig. 4C). Common TFs were mainly HIF1α and HIF2α transcription factors as well as 
genes from the “ETS1 factor family” (V$ETSF), which are among others involved in BMP-signaling and cellular 
response to oxidative stress. The normoxic TF-gene networks resulted in 2,275 nodes, 63,209 edges for the podo-
cyte network, and 1,255 nodes, 21,204 edges for the HK-2 network (Fig. 5).
GlobalNet and Pathway analysis. To get a more focused view on the regulatory mechanisms under-
lying the investigated conditions, we compared for each condition the TF-gene networks of each cell line with 
GlobalNet, a human protein-protein-interaction network22. The resulting protein-protein-interaction networks 
were collected for each cell line and then intersected to identify protein-protein-interaction networks that were 
Figure 2. Scheme describing the workflow of microarray analysis.
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enriched in both cell lines or were exclusively related to either cell line under hypoxic or normoxic conditions 
(Supplementary Figure 5). To integrate the resulting protein-protein-interaction networks into a functional con-
text, we finally subjected these networks to a pathway analysis using the Pathway System GePS from Genomatix 
(Tables 2 and 3 and Supplementary Table 6). Pathways which were found in both cell lines under hypoxic con-
ditions, included among others the “HIF1-alpha and HIF2-alpha transcription factor network” as well as the 
“BMP2 signaling” pathway, while the “Angiopoietin receptor Tie2-mediated signaling” and “NOTCH pathway” 
were among the podocyte exclusive pathways. In HK-2 cells the “EGFR1 pathway” as well as “mapkinase sign-
aling pathway” seemed to play a major role (Table 2). Also under normoxic conditions the “BMP2 signaling” 
pathway seemed to be involved in both cell lines. Furthermore the “Integrin-1 pathway”, “CXCR3 pathway” and 
“PDGFR-beta pathway” were enriched in podocytes and HK-2 cells. Podocyte-exclusive pathways under nor-
moxia include pathways involved in “estrogen receptor signaling”, “p38 and TGFbeta signaling” as well as the 
“RXR and VDR pathway”. In HK-2 cells the “Calcineurin-dependent NFAT signaling”, the “IL12-STAT4 pathway” 
and the “alternative NFkB pathway” were enriched (Table 3).
Many of the identified biological pathways are described to be involved in CKD development and pro-
gression. Analysis of the gene expression of the pathway members could confirm the dysregulation of the 
hypoxia-interconnected pathways in glomeruli and tubulointerstitium in CKD (Supplementary Table 7) and 
revealed an increased dysregulation of these pathways with disease progression (Figure 6). Gender-specific anal-
ysis showed mainly differences in early stages, while with progression of the disease dysregulation of the pathways 
were similar in both sexes (Supplementary Table 7).
Discussion
CKD strongly influences whole body homeostasis. With progressive loss of renal function, patients with CKD 
develop beside anemia disturbances in electrolyte, water and acid-base homeostasis, as well as rapid athero-
sclerosis and osteopathy. Previous studies could demonstrate that oxygen sensing and hypoxia-associated gene 
regulation seem to be central mechanisms in the developing, mature and diseased kidney23. Different detection 
methods such as O2 microelectrodes, pimonidazole staining or transgenic mice have been used to reveal renal 
hypoxia in vivo in different animal models, including glomerulonephritis, polycystic kidney disease, unilateral 
Figure 3. GO enrichment analysis: network visualization for the common and exclusively enriched GOs in the 
different cell lines using the Cytoscape plugins BinGO and EnrichmentMap. Red nodes represent enriched GO-
terms, node size corresponds to negative logarithm of FDR-corrected p-value. Edge thickness shows overlap 
of genes between neighbor nodes. Figures (A) and (B) represent networks of GO-Terms which are exclusively 
associated with AB81 (A) and HK-2 (B) under hypoxic condition, figure (C) displays the network of common 
GO-Terms in AB81 and HK-2 under hypoxia. Figures (D–E) show the exlusive AB81 (D), HK-2 (E) GO-Terms 
under normoxic conditions. There were no common GO-Terms under normoxic conditions.
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ureteral obstruction (UUO) and the aging kidney6, 24. Due to this accumulating evidence Fine and Norman6 
suggested the “chronic hypoxia hypothesis”, where hypoxia plays a key role in loss of renal function and develop-
ment of CKD. However, human data supporting the “chronic hypoxia hypothesis” are difficult to generate and are 
therefore limited. In this study, we assessed the expression of hypoxia-associated genes in genome-wide expres-
sion profiles of more than 200 renal biopsies from patients with different CKD stages which revealed significant 
correlation of several HIF-target genes with eGFR in the glomerular samples and cortical tubulointerstitium. 
These correlations were both positive and negative and in part compartment-specific. Our data clearly point to a 
compartment-specific dysregulation of hypoxia-associated gene transcripts. While the observed enrichment for 
hypoxia-associated genes being correlated with eGFR is very unlikely to have occurred just by chance for glomer-
ular samples, the eGFR correlation with tubulointerstitial expression patterns does not seem to be specific for 
hypoxia-associated genes as shown by the bootstrapping analysis. Although the expression of HIF-target genes is 
only an indirect measure for hypoxia, our data do not seem to support the hypothesis of an overall hypoxic milieu 
in the diseased kidney. In line with these results are BOLD-MRI studies in CKD patients. While some studies 
showed a decrease in oxygen tension in the human kidneys with CKD using BOLD-MRI18, 25–27, others could not 
demonstrate a loss of oxygenation in kidneys of different degrees of kidney function28, 29. However, we cannot 
exclude that environmental factors in the CKD milieu, such as uremia or oxidative stress, might modulate HIF 
function and thereby influence the hypoxic response and the expression of respective HIF target genes. A recent 
study by Tanaka et al. could demonstrate that indoxyl sulfate, a uremic toxin, impaired the hypoxic response 
in proximal tubular cells and in experimental CKD by mRNA stabilization of CITED2. Elimination of indoxyl 
sulfate by AST-120 restored the hypoxic expression of HIF target genes30. In recent years several lines of evidence 
suggest hypoxia as a powerful stimulus regulating the expression of selective miRNAs. These hypoxia-induced 
miRNAs play important roles in metabolism, cell cycle progression, apoptosis or angiogenesis31. However, the 
roles of a miRNA can vary depending on the setting. E.g. miR-21, a miRNA involved in renal fibrosis and the 
pathogenesis of ischemia/reperfusion injury, seems to regulate both protective and pathological pathways. While 
preconditioning-induced upregulation of miR-21 contributes to the protection against subsequent renal I/R 
injury, long-term elevation of miR-21 seems to be detrimental to the organ by promoting the development of 
renal interstitial fibrosis following I/R injury32.
As we found in part a compartment-specific regulation of selected HIF-target genes, we analyzed the impact 
of HIF1α and/or HIF2α in two renal cell lines – AB81, an immortalized human podocyte cell line, and HK-2, a 
human proximal tubular cell line. We chose these cell lines, as in previous studies we could show that podocytes 
in the glomerulus16 and proximal tubular cells in the tubulointerstitium15 seem to be the prominently effected 
cells in kidneys of patients with nephrosclerosis or diabetic nephropathy (DN). To assess the transcriptional 
impact of HIFs in the different cell lines genome-wide gene expression profiles of stable HIF1α and/or HIF2α 
Figure 4. Transcription factor (TF) - gene regulatory networks (under hypoxic conditions). The podocyte 
TF-gene network (A) consists of 1837 nodes, 53175 edges. The tubular network (B) is compiled of 775 nodes 
and 24799 edges. Figure (C) shows the intersection of the podocyte and tubular network. Red nodes represent 
transcription factors, white nodes correspond to regulated genes. Edges connect TFs with their target genes.
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knockdowns from each cell line under normoxic and hypoxic conditions have been generated and analyzed. The 
podocyte cell line seemed to be more susceptible to hypoxia than HK-2 cells, as a higher fraction of genes were 
significantly dysregulated under hypoxic condition. Interestingly, this would be in accordance with the eGFR 
correlation and bootstrapping analysis results.
To understand the biological context behind the transcriptional regulation in the different cell lines, we inves-
tigated hypoxia-specific gene sets associated with the respective activation program, applying WGCNA which 
identifies groups of genes that showed highly correlated gene expression across four cell groups (wt, HIF1kd, 
HIF2kd, HIF1 + 2kd) under hypoxic or normoxic conditions. Combination with a GO enrichment analysis, 
TF-gene network and pathway analysis allowed us to distinguish between common and specific biological pro-
cesses and regulatory mechanisms between the two cell lines.
Biological processes which have been common in podocytes and HK-2 cells under hypoxic conditions 
involved kidney development and uretic bud morphogenesis. This is in accordance with previous studies, which 
could show that during development kidneys are exposed to hypoxia33. A recent study could demonstrate that 
hypoxia significantly reduced the size of metanephric kidneys, as well as the number of branches and glomeruli 
at development34. Along with these studies is our enrichment analysis of the HIF1α and HIF2α transcription 
factor network in both cells. Additionally, we identified “BMP2-signaling pathway” being influenced in both cell 
lines under hypoxic conditions. Bone morphogenic proteins (BMPs) belong to the TGF-β superfamily and have 
been shown to regulate among others kidney development and the pattern of the uretic tree35. Perturbations in 
BMP-signaling pathways have been linked to developmental disorders as well as to the pathophysiology of several 
diseases, including renal fibrosis and kidney diseases. E.g. BMP7 has been described as being protective to adult 
nephrons and to have strong anti-fibrotic activity by counteracting the effects of TGFβ136, 37. Our gene expression 
analysis of different CKD stages showed a significant loss of BMP7 with loss of renal function, while TGFβ1 was 
significantly upregulated (Supplementary Table 7, Fig. 6), indicating a shift towards profibrotic activity with CKD 
progression. BMPs as well as TGFβ transduce their signals through SMAD and non-SMAD signaling pathways. 
Recent studies showed an interaction of HIF1α with SMAD3, a downstream transcription factor of TGFβ sign-
aling, supporting a possible role in kidney injury and glomerulosclerosis, by activation of profibrotic genes such 
as COL1A1, 2 or SERPINE138, 39.
The podocyte is a highly-specialized cell type with unique structure. One characteristic of mature podocytes is 
their terminal differentiation status and thereby their lack of proliferation. However, under certain circumstances 
such as collapsing focal segmental glomerulosclerosis podocytes seem to be able to reenter the cell cycle, leading 
to cell proliferation40, 41, mitotic catastrophe with subsequent cell death and glomerulosclerosis42. Notch, which is 
Figure 5. Transcription factor (TF) - gene regulatory networks (under normoxic conditions). The podocyte 
TF-gene network (A) consists of 2275 nodes, 63209 edges. The tubular network (B) is compiled of 1255 nodes 
and 21204 edges. Figure (C) shows the intersection of the podocyte and tubular network. Red nodes represent 
transcription factors, white nodes correspond to regulated genes. Edges connect TFs with their target genes.
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normally not expressed in healthy glomeruli, has been identified as one important regulator for the re-entrance 
into the cell cycle43, 44. In this study, among the identified podocyte-specific processes and pathways cell cycle 
and cell division processes as well as the Notch pathway have been specified, indicating a crosslink of hypoxia to 
Notch and cell cycle deregulation in the podocytes. From the module coexpression analysis we found an associa-
tion of these podocyte-specific processes with HIF1α and/or HIF2α. A study by Gustaffson and colleagues could 
demonstrate, that hypoxia activates Notch signaling due to the association of Notch and HIF1α thereby negatively 
blocking cell differentiation45.
Another major activated/impaired GO-subcluster in the podocyte cells that has been identified in this study is 
the steroid/cholesterol metabolism. This corresponds with several studies which could show that lipids and cho-
lesterol are important for the podocyte structure and function, so e.g. cholesterol is required for the localization 
and function of the slit-diaphragm proteins in the lipid rafts46. Recently, it has been demonstrated that an imbal-
ance in the cholesterol homeostasis due to increased synthesis, influx or decreased efflux is associated with the 
development of proteinuric diseases such as minimal change disease, focal segmental glomerulosclerosis (FSGS) 
or DN47, e.g. patients with mutations in genes of the cholesterol metabolism such as APOL1 or APOE were shown 
to be more susceptible to FSGS (APOL1) or develop a lipoprotein glomerulopathy (APOE), while patients with 
DN showed a reduced expression of ABAC1, indicating that lipid accumulation in podocytes might be due to a 
defective cellular cholesterol homeostasis47.
In the tested HK-2 cells major regulated gene clusters were related to morphogenesis/tube formation and 
regulation of angiogenesis. Previous studies have shown that VEGFA, which is mainly expressed by podocytes 
and proximal tubular cells, induces capillary formation by endothelial cells and that hypoxia augments branch-
ing angiogenesis48. CKD is often associated with rarefaction of peritubular capillaries, leading to a decrease in 
oxygen supply, finally resulting in hypoxia. In advanced stages of CKD VEGFA expression is reduced15, 17. In 
accordance with the regulation of angiogenesis and morphogenesis in hypoxic HK-2 cells is, besides BMP2 
signaling, the enrichment for the AP1 transcription factor network and EGFR1-signaling pathway, which are 
both important pathways that regulate growth, survival, proliferation, and differentiation. A study by Kolev et al. 
could show that EGFR signaling is a negative regulator of Notch1, promoting cell proliferation and that knock-
down of c-Jun and c-Fos, downstream effectors of EGFR, lead to an induction of Notch149. In our study, most 
Canonical pathway Pathway id
AB81_exclusive network HK2_exclusive network Intersection AB81_HK2
p-value Adj p-value p-value Adj p-value p-value Adj p-value
Alk in cardiac myocytes BioCarta:alkpathway 1.73E-04 0.00E+00 4.23E-04 1.00E-03
BMP2 signaling 
pathway(through Smad) INOH:BMP2_signaling_TGF-beta_MV 8.70E-03 8.00E-03 2.17E-04 0.00E+00
Circadian rhythm pathway NCI-nature:circadianpathway 2.30E-03 2.00E-03
HIF-1-alpha transcription factor 
network NCI-nature:hif1_tfpathway 8.80E-05 0.00E+00 6.26E-04 0.00E+00
HIF-2-alpha transcription factor 
network NCI-nature:hif2pathway 1.79E-03 2.00E-03 1.80E-03 2.00E-03 1.77E-04 0.00E+00
Hypoxic and oxygen 
homeostasis regulation of HIF-
1-alpha
NCI-nature:hif1apathway 6.12E-03 1.00E-02 3.21E-03 3.00E-03
ID CellMap:ID 3.40E-04 0.00E+00 7.95E-03 6.00E-03
Mets affect on macrophage 
differentiation BioCarta:etspathway 2.73E-03 2.00E-03
Angiopoietin receptor Tie2-
mediated signaling NCI-nature:angiopoietinreceptor_pathway 1.02E-03 2.00E-03
Estrogen responsive protein efp 
controls cell cycle and breast 
tumors growth
BioCarta:efppathway 2.33E-03 0.00E+00
nfkb activation by nontypeable 
hemophilus influenzae BioCarta:nthipathway 2.08E-03 3.00E-03
NOTCH CellMap:NOTCH 1.84E-03 3.00E-03
AP-1 transcription factor 
network NCI-nature:ap1_pathway 9.35E-06 0.00E+00
EGFR1 CellMap:EGFR1 5.30E-03 1.00E-03
Mapkinase signaling pathway BioCarta:mapkpathway 4.92E-03 5.00E-03
Overview of telomerase 
protein component gene htert 
transcriptional regulation
BioCarta:tertpathway 5.37E-03 7.00E-03
Regulation of retinoblastoma 
protein NCI-nature:rb_1pathway 3.57E-03 4.00E-03
Signaling mediated by p38-alpha 
and p38-beta NCI-nature:p38alphabeta-downstreampathway 1.00E-04 0.00E+00
Table 2. Summary of canonical signal transduction pathways. Adjusted p-value: corresponds to a p-value that 
is estimated from the results of 1,000 simulated null hypothesis queries65.
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processes of these clusters were related to modules which correlated mainly to wild type HK-2 cells, indicating 
that hypoxia-inducible factors do not play a major role in these processes.
Most of the hypoxia associated biological processes in the podocytes were also found in the normoxic anal-
ysis indicating a HIF1 and/or HIF2-dependencies of these processes. In HK-2 cells, however, only processes 
involved in cell migration seemed to be common under both normoxic and hypoxic conditions, while most of the 
observed hypoxia associated processes (at 24 h) did not show evidence for direct HIF-dependency.
While HIF1α is preferentially involved in glycolytic pathways, HIF2α is among others involved in the regu-
lation of angiogenesis, cell cycle progression and cell proliferation50, which is in accordance with the finding that 
Canonical pathway Pathway id
AB81_exclusive network HK2_exclusive network Intersection AB81_HK2
P-value Adj p-value P-value Adj p-value P-value Adj p-value
AKT(PKB) activation signaling 
(Insulin receptor signaling 
(Mammal))
INOH:insulin_Mam 8.28E-03 6.00E-03
Beta1 integrin cell surface 
interactions NCI-nature:integrin1_pathway 1.08E-03 1.00E-03
BMP receptor signaling NCI-nature:bmppathway 2.18E-03 1.00E-03
BMP2 signaling pathway(through 
TAK1) INOH:BMP2_signaling_TAK1 1.68E-03 2.00E-03 8.61E-03 9.00E-03
CXCR3-mediated signaling events NCI-nature:cxcr3pathway 4.29E-04 0.00E + 00 4.27E-03 3.00E-03
human cytomegalovirus and map 
kinase pathways BioCarta:hcmvpathway 2.05E-03 0.00E + 00
PDGFR-beta signaling pathway NCI-nature:pdgfrbpathway 3.12E-03 2.00E-03 1.54E-03 2.00E-03
A6b1 and a6b4 Integrin signaling NCI-nature:a6b1_a6b4_integrin_pathway 6.88E-03 4.00E-03
Aspirin blocks signaling pathway 
involved in platelet activation BioCarta:sppapathway 3.52E-03 4.00E-03
ATF-2 transcription factor network NCI-nature:atf2_pathway 5.16E-03 7.00E-03
Aurora B signaling NCI-nature:aurora_b_pathway 9.19E-03 5.00E-03
Ctcf: first multivalent nuclear factor BioCarta:ctcfpathway 4.21E-03 5.00E-03
EGF receptor proximal signaling NCI-nature:erbb1_receptor_proximal_pathway 2.70E-03 2.00E-03
EPHB forward signaling NCI-nature:ephbfwdpathway 2.20E-03 3.00E-03
Internalization of ErbB1 NCI-nature:erbb1_internalization_pathway 4.30E-03 5.00E-03
Nfkb activation by nontypeable 
hemophilus influenzae BioCarta:nthipathway 1.33E-03 1.00E-03
p38 cascade (TGF-beta 
signaling(through TAK1)) INOH:TGF-beta_signaling_TAK1 1.71E-03 3.00E-03
p38 signaling mediated by 
MAPKAP kinases NCI-nature:p38_mk2pathway 2.36E-03 2.00E-03
Phosphorylation of mek1 by cdk5/
p35 down regulates the map kinase 
pathway
BioCarta:cdk5pathway 7.31E-03 6.00E-03
Plasma membrane estrogen receptor 
signaling NCI-nature:er_nongenomic_pathway 8.93E-04 0.00E + 00
Ras signaling in the CD4 + TCR 
pathway NCI-nature:tcrraspathway 7.31E-03 3.00E-03
RXR and RAR heterodimerization 
with other nuclear receptor NCI-nature:rxr_vdr_pathway 1.39E-04 0.00E + 00
Signaling mediated by p38-alpha 
and p38-beta NCI-nature:p38alphabetadownstreampathway 7.69E-03 8.00E-03
Tgf beta signaling pathway BioCarta:tgfbpathway 8.63E-03 8.00E-03
Trk receptor signaling mediated by 
PI3K and PLC-gamma NCI-nature:pi3kplctrkpathway 1.40E-03 1.00E-03
Alpha-synuclein signaling NCI-nature:alphasynuclein_pathway 6.14E-03 5.00E-03
Alternative NF-kappaB pathway NCI-nature:nfkappabalternativepathway 7.67E-03 7.00E-03
Amb2 Integrin signaling NCI-nature:amb2_neutrophils_pathway 5.82E-03 5.00E-03
Calcium signaling in the 
CD4 + TCR pathway NCI-nature:tcrcalciumpathway 4.85E-03 3.00E-03
FoxO family signaling NCI-nature:foxopathway 6.34E-03 5.00E-03
IL12 signaling mediated by STAT4 NCI-nature:il12_stat4pathway 1.17E-03 2.00E-03
Role of Calcineurin-dependent 
NFAT signaling in lymphocytes NCI-nature:nfat_3pathway 1.32E-03 1.00E-03
Validated transcriptional targets of 
AP1 family members Fra1 and Fra2 NCI-nature:fra_pathway 9.37E-03 9.00E-03
Table 3. Summary of canonical signal transduction pathways (Normoxia). Adjusted p-value: corresponds to a 
p-value that is estimated from the results of 1,000 simulated null hypothesis queries65.
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podocyte undergo cell cycle dysregulation under hypoxic conditions and are known to express HIF2α. When 
we intersected the TF-gene networks of the two cell lines, HK-2 and podocytes, we found a very small overlap, 
mostly involving HIF transcription factors and factors of the ETS-family. ETS transcription factors have been 
shown to cooperate specifically with HIF2α (EPO, VEGFR2, CITED2) and thereby promote angiogenesis51.
In conclusion, our data clearly point to a compartment- and cell type-specific dysregulation of 
hypoxia-associated gene transcripts. Co-expression and network analysis of HIF-knockdown cells identified 
biological processes and pathways known to be involved in the development of CKD. Comparison of these 
hypoxia-interconnected pathways with gene expression data of patients with different CKD stages revealed an 
increased dysregulation of the pathways with growing loss of renal function. With currently several clinical trials 
of novel PHD enzyme inhibitors for the treatment of renal anemia being performed, a better understanding of 
the renal oxygen signaling pathway becomes even more important. Our dataset might thereby help to obtain 
an improved understanding of the renal effects of hypoxia, HIF dysregulation and the transcriptional program 
response in CKD.
Material and Methods
Patient characteristics. Human renal biopsy specimens and Affymetrix microarray expression data were 
procured within the framework of the European Renal cDNA Bank - Kröner-Fresenius Biopsy Bank52, 53. Biopsies 
were obtained from patients after informed consent and with approval of the local ethics committees (Specialized 
Ethics Subcommittee of Internal Medicine of the University Hospital Zurich, Cantonal Ethics Committee Zurich 
and Ethics Committee of the Medical Faculty of the University of Munich (LMU)). All methods were performed 
in accordance with the relevant guidelines and regulations. Histology reports, clinical data, and gene expres-
sion information were stored in a de-identified manner. A total of 362 microarrays from kidney biopsies of 201 
patients were used for gene expression analysis and kidney function correlation analysis (GSE47185, GSE32591, 
GSE37463). Demographic data of these 194 patients are provided in Supplementary Table 8.
RNA Isolation, RNA Preparation, and Microarray Data Analyses of microdissected human 
kidney biopsies. Following renal biopsy, the tissue was transferred to RNase inhibitor and microdissected 
into glomerular and tubulointerstitial fragments. Total RNA was isolated from microdissected glomeruli and 
tubulointerstitium, reverse transcribed, and linearly amplified according to a protocol previously reported54. 
Figure 6. Visualization of the interplay of the significantly enriched pathways in CKD development 
progression. Increased dysregulation of the hypoxia-interconnected pathways with loss of renal function in 
glomerular (A) and tubulointerstitial (B) samples. Color represents the log2 expression foldchange, node size 
the absolute value of the log2 foldchange, edge color represents the pathway. Directionality is based on pathway 
information and represented by arrows. Red means upregulated, blue downregulated compared to CKD1.
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Affymetrix GeneChip Human Genome U133A and U133 Plus2.0 Arrays were used in this study. The microarray 
expression data came from individual patients with different chronic kidney diseases (cadaveric donor (CD), 
tumor nephrectomy (TN), diabetic nephropathy (DN), thin basement disease (TMD), minimal change disease 
(MCD), hypertensive nephropathy (HTN), IgA nephropathy (IgA), focal segmental glomerulosclerosis (FSGS), 
membranous nephropathy (MGN), lupus nephritis (LN) and ANCA-vasculitis (ANCA)). Fragmentation, 
hybridization, staining, and imaging were performed according to the Affymetrix Expression Analysis Technical 
Manual (Affymetrix, Santa Clara, CA). The raw data was normalized using Robust Multichip Algorithm (RMA) 
and annotated by Human Entrez Gene custom CDF annotation version 18 (http://brainarray.mbni.med.umich.
edu/Brainarray/default.asp). The log transformed dataset was corrected for batch effect using ComBat from the 
GenePattern pipeline (http://www.broadinstitute.org/cancer/software/genepattern/)55. Normalized data are avail-
able at the Gene Expression Omnibus (GEO) Web site (http://www.ncbi.nlm.nih.gov/geo/) under accession num-
ber GSE99340.
Correlation of gene expression data with clinical parameters and differential gene expression 
analysis. To analyze the overrepresentation of HIF-induced genes in CKD, we compiled a list of well-known 
HIF target genes from the literature. Only HIF targets in which binding of HIF to the target DNA sequence 
in a DNA binding assay, a functional transactivation of reporter gene expression or a knock-down experiment 
has been shown were selected (resulting in a list of 84 HIF-target genes, Supplementary Table 9)20, 21. Except of 
one gene (LDHA) all genes were found on the Affymetrix microarray HG-U133A. We refer to these 83 genes 
as HIF target genes. Tubulointerstitial and glomerular gene expression profiles from patients with different 
chronic kidney diseases (cadaveric donor (CD), tumor nephrectomy (TN), diabetic nephropathy (DN), thin 
basement disease (TMD), minimal change disease (MCD), hypertensive nephropathy (HTN), IgA nephropathy 
(IgA), focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MGN), lupus nephritis (LN) and 
ANCA-vasculitis (ANCA)) were used to compute the correlation of estimated GFR (eGFR) calculated by the 
CKD Epidemiology Collaboration (CKD-EPI) equation56 with the log-transformed steady-state expression levels 
of the HIF target genes within each subject using Spearman correlation. Disease cohort sizes ranged from 3 to 30 
patients, with LN (30 patients) and IgA (26 patients) being the largest subcohorts. To assess the effect of demo-
graphic factors such as gender, correlation analyses were performed separately for females and males.
For the differential gene expression analysis the patients were grouped into different CKD stages (CKD1-5) 
according to their estimated GFR calculated by the CKD-EPI equation57 (Glom: CKD1: n = 55; CKD2: n = 52; 
CKD3: n = 44; CKD4: n = 26; CKD5: n = 10; Tub: CKD1: n = 56; CKD2: n = 46; CKD3: n = 37; CKD4: n = 26; 
CKD5: n = 10), where the CKD1 group served as the control group. To identify differentially expressed genes the 
SAM (Significance analysis of Microarrays) method was applied using TiGR (MeV, Version 4.8.1)58. A q-value 
below 5% was considered to be statistically significant. Additionally, we assessed to what extent gene expression 
changes were observed in both sexes by performing the differential gene expression analysis separately for females 
and males.
Immunohistochemistry on biopsies for selected HIF target genes/Tissue array. Sections from 
paraffin embedded kidney biopsies with chronic kidney disease (normal and reduced eGFR) and kidney tissue 
obtained from tumor nephrectomy specimens (n = 54) were stained with antibodies against HIF1α, VEGFA, and 
ABCG2. After antigen retrieval, slides were incubated with the following antibodies: HIF1α clone mgc3 ab16066 
(Abcam, Cambridge, UK), dilution 1:400; VEGFA sc-152 (Santa Cruz Biotechnology), dilution 1:300; ABCG2 
ab3380 (Abcam, Cambridge, UK), dilution 1:60. The immunohistochemical staining was conducted on auto-
mated staining systems (ABCG2 on Ventana BenchMark, Ventana Medical Systems, USA; HIF1α and VEGFA 
on Leica Bond System, Leica Biosystems) following the manufacturer’s instructions. Visualization was performed 
using the avidin–biotin complex method leading to a brown staining signal. For all stainings the intensity in the 
glomerular and tubulointerstitial compartment (negative = score 0, weak = score 1, strong = score 2) in compar-
ison to expression in normal tissue was assessed. Statistical analysis using Fisher’s exact test was performed with 
SPSS statistics software version 22 (IBM, USA). p-values < 0.05 were considered as significant.
Cell Culture. Immortalized human podocytes (AB81) and human proximal tubular epithelial cells (HK-2, 
(ATCC CRL-2190)) were cultured as described before16, 59. Briefly, conditionally immortalized human podocytes 
were cultured under permissive conditions (33 °C) in RPMI-1640 supplemented with 10% FBS, penicillin (100 U/
ml)/streptomycin (100 µg/ml), and 1% ITS. Differentiation was induced by thermoshift to 37 °C in 6-well plates 
(RNA isolation) and 15 cm dishes (protein isolation). HK-2 cells were cultured in DMEM/F-12 supplemented 
with 10% fetal calf serum (FCS), 1% ITS, hydrocortisone (36 ng/ml), penicillin (100 U/ml) and streptomycin 
(100 µg/ml). The cells were incubated at 37 °C.
Normoxia was defined as 20% O2 in the gas phase and hypoxia constituted 1.0% O2, respectively. For oxygen 
titration, cell cultures were distributed into incubators (Binder, Tuttlingen, Germany) with different oxygen con-
centrations (1.0% and 20% O2) and simultaneously cultured for the respective time. Cells were harvested and 
analyzed for HIF1α and HIF2α expression by Western blot and mRNA expression analysis, respectively. Total 
cellular RNA was extracted using the Qiagen RNeasy kit (Qiagen, Hombrechtikon, Switzerland). mRNA levels 
were analyzed by real-time RT-PCR and microarray experiments.
HIFα knock-down cells and lentiviral infections. shHIF1A knock-down cells were generated by trans-
fection with a pLKO.1-puro vector expressing U6 promoter driven shRNA targeting nucleotides 1168–1188 of 
human HIF1A (NM_001530.x-1048s1c1, Sigma). Cell clones were derived by puromycin selection (8 μg/ml) and 
ring cloning. For shHIF2A knock-down cells a lentiviral expression vector encoding a shRNA sequence targeting 
human HIF2A at nucleotides 2055–2075 (NM_001430.x-1694s1c1) in a pLKO.1-puro plasmid was purchased 
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from Sigma. Variants of shRNA expression plasmids bearing a blasticidin resistance marker were generated by 
replacing the original puromycin resistance cassette in pLKO.1. Viral particles were produced in HEK293T cells 
by co-transfection of the respective transfer vector (3 μg) with the packaging plasmids pLP1 (4.2 μg), pLP2 (2 μg) 
and pVSV-G (2.8 μg, all from Invitrogen) using PEI transfection as described before57. Podocytes and HK-2 cells 
were infected with lentiviral-pseudotyped particles and cell pools were derived by puromycin (8 μg/ml) and/or 
blasticidin (20 μg/ml) selection.
Western Blot analysis. For HIF1α detection, cultured cells were harvested with lysis buffer (10 mM 
Tris-HCl [pH 8.0], 0.1% Nonidet P-40, 400 mM NaCl, 1 mM EDTA [pH 8.0], and 1 mM DTT, 1 mM PMSF and 
Complete Protease Inhibitor Cocktail (Roche, Mannheim, Germany)). For HIF2α detection, cells were harvested 
with a lysis buffer containing 8 M urea (10 mM Tris-HCl [pH 6.8], 1% SDS, 5 mM DTT, 10% Glycerol, 8 M Urea, 
0.5 mM PMSF and Complete Protease Inhibitor Cocktail (Roche, Mannheim, Germany)). The protein concen-
trations were determined by the Bradford method (Bio-Rad). Extracted proteins were boiled in loading buffer for 
5 min, resolved by 10% SDS-PAGE under reducing conditions, and transferred to an Immobilon-P membrane 
(Millipore, Eschborn, Germany). Equal loading and transfer efficiency were verified by staining with 2% Ponceau 
S. Membranes were blocked overnight with Tris-buffered saline (TBS) / 5% fat-free skim milk and then incubated 
with a monoclonal mouse antibody raised against human HIF1α (BD Transduction Laboratories, Lexington, KY) 
diluted 1:1000 overnight at 4 °C, and rinsed with TBS that contained 0.1% Tween 20. HIF2α was detected using a 
polyclonal rabbit anti-HIF2α antibody (1:200, overnight at 4 °C; Novus Biologicals, Littleton, CO, USA).
For detection, a horseradish peroxidase–linked anti–mouse IgG antibody (1:2000, 1 hour at room tem-
perature; DAKO, Glostrup, Denmark) and enhanced chemiluminescence substrate (PerkinElmer) were used. 
Membranes were also probed with anti-beta-actin antibody (A 5316, 1:5000, Sigma-Aldrich, Germany) as inter-
nal loading control.
Microarray analysis of HIFα knock-down cells. For oxygen titration, cell cultures were distrib-
uted into incubators (Binder, Tuttlingen, Germany) with different oxygen concentrations (1.0% and 20% 
O2) and simultaneously cultured for 24 hours. Total cellular RNA was extracted using the Qiagen RNeasy kit 
(Qiagen, Hombrechtikon, Switzerland). For RNA amplification which was performed with the OvationTM RNA 
Amplification System V2 (NuGen Inc), 50 ng of total RNA was used. The amplified cDNA was purified according 
to the manual instruction using Agentcourt Beads RNA Clean (Agencourt – Beckman Coulter Genomics). For 
fragmentation and biotin labelling 3.3 µg of each amplified cDNA was processed with the NuGen Encore Biotin 
Module (NuGen Inc.). All sample processing procedures were performed according to the user manuals. Quality 
control of all steps was determined by the Agilent Bioanalyzer. cDNA was hybridized to Affymetrix GeneChip 
Human Genome U133Plus2.0. Hybridization, staining, and imaging were performed according to the Affymetrix 
Expression Analysis Technical Manual (Affymetrix, Santa Clara, CA). The raw data was normalized using Robust 
Multichip Algorithm (RMA) and annotated by Human Entrez Gene custom CDF annotation version 18 (http://
brainarray.mbni.med.umich.edu/Brainarray/default.asp). For HK-2 data, a batch correction using ComBat from 
the GenePattern pipeline (http://www.broadinstitute.org/cancer/software/genepattern/) was applied55, as these 
data originated from different batches. To identify differentially expressed genes the SAM (Significance analysis 
of Microarrays) method was applied using TiGR (MeV, Version 4.8.1)58. A q-value below 5% was considered to be 
statistically significant. Normalized data are available at the Gene Expression Omnibus (GEO) Web site (http://
www.ncbi.nlm.nih.gov/geo/) under accession number GSE99340.
Weighted Gene Coexpression Network Analysis (WGCNA). Prior to WGCNA, the gene expression 
data were pre-processed with RMA. For HK-2 data, a batch correction using ComBat from the GenePattern pipe-
line (http://www.broadinstitute.org/cancer/software/genepattern/) was applied55, as these data originated from 
different batches, in contrast to AB81 data. Individual weighted gene co-expression network analyses (WGCNA)60 
were performed individually for AB81 and HK-2 cells, respectively, using WGCNA for R, version 1.41-1. For both 
cell types, two analyses were done: one with sub-division for knockdown type (wt, HIF1kd, HIF2kd, HIF1 + 2kd) 
and the other with respect to hypoxic/normoxic conditions. Each WGCNA was performed as follows. First, the 
30% of genes being most variable in their gene expression across samples of the same type (e.g. HIF1kd) were 
selected for further analysis. Genes and samples were then tested for too many missing values with the method 
goodSamplesGenes of WGCNA package for R. Search for outlying samples was performed according to WGCNA 
default settings. None of the samples had to be removed. The soft threshold (power value), which is critical for 
WGCNA, was determined according to WGCNA tutorial recommendation by choosing the lowest power value 
which gives an R^2 of at least 0.7 for the scale free topology model fit. The remaining WGCNA parameters were 
set as follows: mergeCutHeight 0.05 for Hypoxia/Normoxia and 0.3 for knockdown type analyses, respectively, 
minModuleSize 50, minCoreKME 0.9 and minKMEtoStay 0.85. KME describes the correlation of a gene’s expres-
sion profile with that of the first principal component of the expression matrix. The first principal component is 
called a module eigengene (ME). The KME value can thus be interpreted as a module membership value for a 
gene and a WGCNA module. The MEs were calculated for all modules and a ME-to-treat (condition) correlation 
was determined which was visualized as a heatmap. To distinguish one module from another, each module was 
assigned a color, with grey being reserved for the unassigned genes.
GO Term Enrichment Analysis. For the gene modules originating from WGCNA, individual GO Term 
Enrichment Analyses were performed with the Cytoscape plugin BinGO (BinGO Version 3.03; Cytoscape 
Version 3.2.1)61. GO Terms were called significant when their Benjamini-Hochberg-corrected p-value (FDR) for 
enrichment was below 0.05. The significant GO Terms were collected across all modules of the same WGCNA 
and were then compared against the significant GO Terms from the respective WGCNA (e.g. the GO Terms of 
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AB81 under hypoxic conditions were compared with those of AB81 under normoxic conditions). These compari-
sons gave GO Terms that were common between (e.g. hypoxic and normoxic) conditions and also GO Terms that 
were exclusively enriched in only one of both conditions. Visualization of GO-enrichment was performed using 
the Cytoscape plugin EnrichmentMap (EnrichmentMap v2.0.1)62.
TF Enrichment Analysis with Genomatix. WGCNA-based gene modules were used as gene sets for the 
overrepresented transcription factor binding sites (OTFBS) analysis (Genomatix). From the hypoxia and nor-
moxia experiments in each cell line (AB81 and HK-2) only gene modules with a heatmap correlation coefficient 
≥0.8 and p values < 0.01 and <0.001 were chosen and compared against each other to select unique and common 
genes between cell lines. Only unique cell line genes underwent the OTFBS analysis and only TF Families with 
the Z score (promoter) >3 were taken into further calculation. Here, the Z-scores are calculated with a continu-
ity correction using the formula z = (x-E-0.5)/S, where x is the number of found matches in the input data, E is 
the expected value and S is the standard deviation (Genomatix). In each cell line, TF families from different cell 
groups (wt, HIF1kd, HIF2kd, HIF1 + 2kd) were compared to obtain TF families common in all analyzed cell 
groups and those which were found in at least one group. Common TF families were excluded from the analysis 
and only the top 10 (according to Z score (promoter)) of each cell group were used to conduct transcription 
factor-genes network. The TF families that were identified with the Genomatix TF enrichment analysis (TFEA) 
were broken down to those single transcription factors that made a TF family being called enriched by the TFEA 
tool. These enriched TFs and their regulated genes (also defined by Genomatix) were then used to conduct a reg-
ulatory network. Visualization and analysis of the network was done with Cytoscape 3.3.063.
GlobalNet and Pathway analysis. To get a more detailed view on the regulatory mechanisms underlying 
the investigated conditions, we further analyzed the TF-gene networks by emcompassing its intersection with 
GlobalNet – an unfocussed human protein-protein-interaction (PPI) network22. The resulting networks under-
went a pathway analysis using the Genomatix GePS tool. For visualization of the interplay of the significantly 
enriched pathways in CKD development progression, we downloaded their pathway representations with the 
Bioconductor graphite package64. This package allowed us to access the BioCarta and NCI pathways as shown 
in Supplementary Table 7. All individual pathways were combined into a single network and imported into 
Cytoscape 3.3.063. Node color represents the log2 expression foldchange, node size encodes the absolute value 
of the log2 foldchange, edge color represents the pathway. Directionality is based on pathway information and 
represented by arrows.
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